T-cell immunity in human herpesvirus vaccine development: research advances and translational challenges.
This review compares preventive and therapeutic strategies and examines how antigen accessibility, tissue localization, host context, and endpoint selection influence whether measurable cellular immunogenicity translates into virological or clinical benefit across viruses and disease settings.